Quanticate and GSK's strategic partnership goes from strength to strength with contract renewal
June 22, 2021
We are excited to announce that we have again renewed our MSA with GlaxoSmithKline. Quanticate has been in partnership with GSK for several years and continues this key strategic partnership due to our outstanding quality and ability to deliver on time, every time. We will be supporting GSK on various phases and supplying highly skilled resources supporting various therapeutic areas – using a functional service provision and staff augmentation model. The renewal of this MSA demonstrates GSK’s trust in Quanticate as one of their preferred partners.
Quanticate meets the needs of drug and device development companies by offering customer focused resource solutions from fixed cost or functional service provider (FSP) models through to consultancy. Quanticate has become the trusted supplier of choice for many companies from niche biotechnology and device companies to top tier pharmaceutical giants.